Advertisement

Ectopeptidases pp 289-300 | Cite as

CD26/DPIV in Stress-induced, Cytokine-mediated Abortions

  • Martin Hildebrandt
  • Hans-Ulrich Demuth
  • Werner Reutter

Abstract

Dipeptidyl Peptidase IV (DPIV, also known as DPIV or CD26) has a unique enzymatic activity, cleaving dipeptides from peptides and proteins carrying proline in their penultimate position, a feature which protects peptides from being digested by nonspecific proteases (Yaron and Naider, 1993). DPIV is associated with the plasma membrane of a variety of cells, including the venous portion of capillary endothelial cells (Mrazkowa et al 1986), hepatocytes (Kreisel et al 1984), enterocytes (Darmoul et al 1994) and cells of the renal glomeruli and proximal tubuli (Barth et al 1974). Expression of DPIV defines a higher degree of cell maturation and differentiation (Darmoul et al 1992). Organ-specific functions and regulatory circuits appear to have impact on DPIV expression, such as a proline-rich diet in the intestinal epithelium Suzuki et al 1993), γ-interferon in kidney (Stefanowicz et al 1993) and antigenic Schmitz et al 1996) or mitogenic (Plana et al 1991) stimulation of T lymphocytes.

Keywords

Dipeptidyl Peptidase Proximal Tubuli Nonspecific Protease Human Glomerular Epithelial Cell Decisive Mediator 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Arck, P.C., Ferrick, D.A., Steele-Norwood, D., Egan, P.J., Croitoru, K., Carding, S.R., etal 1999, Murine T cell determination of pregnancy outcome. Cell Immunol. 196: 71–79.PubMedCrossRefGoogle Scholar
  2. Arck, P.C., Merali, F.S., Manuel, J., Chaouat, G., and Clark, DA, 1995, Stress-triggered abortion: inhibition of protective suppression and promotion of tumor necrosis factoralpha (TNF-alpha) release as a mechanism triggering resorptions in mice. Am. J. Reprod. Immunol 33: 74–80.PubMedGoogle Scholar
  3. Arck, P.C., Merali, F.S., Stanisz, A.M., Stead, R.H., Chaouat, G., Manuel, J., et al 1995, Stress-induced murine abortion associated with substance P-dependent alteration in cytokines in maternal uterine decidua. Biol. Reprod. 53: 814–819.PubMedCrossRefGoogle Scholar
  4. Barth, A., Schulz, H., and Neubert, K., 1974, Untersuchungen und Charakterisierung der Dipeptidylpeptidase IV. Acta biologica et medica germanica 32: 157–174.PubMedGoogle Scholar
  5. Campbell, R.M., Strieker, P., Miller, R., Bongers, J., Liu, W., Lambros, T., et al, 1994, Enhanced stability and potency of novel growth hormone-releasing factor (GRF) analogues derived from rodent and human GRF sequences. Peptides 15(3): 489–495.PubMedCrossRefGoogle Scholar
  6. Clark, D.A., Chaouat, G., Arck, P.C, Mittruecker, H.W., Levy, G.A., 1998, Cytokinedependent abortion in CBA x DBA/2 mice is mediated by the procoagulant fgl2 prothrombinase. J. Immunol. 160: 545–549.PubMedGoogle Scholar
  7. Darmoul, D., Voisin, T., Couvineau, A., Rouyer Fessard, C., Salomon, R., Wang, Y., et al, 1994, Regional expression of epithelial dipeptidyl peptidase IV in the human intestines. Biochem. Biophys. Res. Commun. 203: 1224–1229.PubMedCrossRefGoogle Scholar
  8. Darmoul, D., Lacasa, M., Baricault, L., Marguet, D., Sapin, C., Trotot, P., et al, 1992, Dipeptidyl peptidase IV (CD 26) gene expression in enterocyte-like colon cancer cell lines HT-29 and Caco-2. Cloning of the complete human coding sequence and changes of dipeptidyl peptidase IV mRNA levels during cell differentiation. J. Biol. Chem. 267: 4824–4833.PubMedGoogle Scholar
  9. De Meester, I., Korom, S., Van Damme, J., and Scharpe, S., 1999, CD26, let it cut or cut it down. Immunol. Today 20: 367.27.Google Scholar
  10. Demuth, H.-U., 1990, Recent developments in the irreversible inhibition of serine and cysteine proteases. J. Enzyme Inhibition 3: 249–278.CrossRefGoogle Scholar
  11. Demuth, H.-U., and Heins, J., On the catalytic Mechanism of Dipeptidyl Peptidase IV, 1995,in Dipeptidyl Peptidase IV (B. Fleischer, Ed.) R.G. Landes, Biomedical Publishers,Georgetown, 1–37.Google Scholar
  12. Hartel-Schenk, S., Minnifield, N., Reutter, W., Hanski, C., Bauer, C., andMone, D.J., 1991,Distribution of glycosyltransferases among Golgi apparatus subtractions from liver and hepatomas of the rat. Biochim. Biophys. Acta 1115: 108–22.PubMedCrossRefGoogle Scholar
  13. Hildebrandt, M., Arck, P., Demuth, H.U., Kruber, S., Reutter, W., and Klapp, B.F., 2001,Inhibition of Dipeptidyl peptidase IV (DP IV, CD26) activity abrogates stress-induced,cytokine-mediated murine abortions. Scand. J. Immunol. 53: 449–454.PubMedCrossRefGoogle Scholar
  14. Hildebrandt, M., Reutter, W., and Gitlin, J.D. 1991, Tissue-specific regulation of dipeptidyl peptidase IV expression during development. Biochem. J. 277(2): 331–334.PubMedGoogle Scholar
  15. Hopsu-Havu, V.K., and Glenner, G.G. 1966, A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-ß-naphthylamide. Histochemie 7: 197–200.PubMedCrossRefGoogle Scholar
  16. Kähne, T., Lendeckel, U., Wrenger, S., Neubert, K., Ansorge, S., and Reinhold, D. 1999,Dipeptidyl peptidase IV: a cell surface peptidase involved in regulating T cell growth. Int.J.Mol.Med. 4: 3–15.PubMedGoogle Scholar
  17. Kähne, T., Neubert, K., and Ansorge, S., 1995, Enzymatic activity of DP IV/CD 26 is involved in PMA-induced hyperphosphorylation of p561ck. Immunol. Lett. 189–193.Google Scholar
  18. Korom, S., De Meester, I., Stadlbauer, T.H., Chandraker, A., Schaub, M., Sayegh, M.H.,Belyaev, A., Haemers, A., Scharpe, S., and Kupiec Weglinski, J.W., 1997, Inhibition of CD26/dipeptidyl peptidase IV activity in vivo prolongs cardiac allograft survival in rat recipients. Transplantation 63: 1495.PubMedCrossRefGoogle Scholar
  19. Kreisel, W., Hildebrandt, H., Mössner, W., Tauber, R., and Reutter, W., 1993,Oligosaccharide reprocessing and recycling of a cell surface glycoprotein in cultured rat hepatocytes. Biol. Chem. Hoppe Seyler 374: 255–263.PubMedCrossRefGoogle Scholar
  20. Kreisel, W., Reutter, W., and Gerok, W., 1984, Modification of the intramolecular heterogeneous turnover of terminal carbohydrates of dipeptidylaminopeptidase IV isolated from rat-liver plasma membrane during liver regeneration. Eur. J. Biochem. 138: 435–8.PubMedCrossRefGoogle Scholar
  21. Krishnan, L., Guilbert, L.J., Wegmann, T.G., Belosevic, M., and Mosmann, T.R., 1996, T helper 1 response against Leishmania major in pregnant C57BL/6 mice increases implantation failure and fetal resorptions. Correlation with increased IFN-gamma and TNF and reduced IL-10 production by placental cells. J. Immunol. 156: 653–662.PubMedGoogle Scholar
  22. Markert, U.R., Arck, P.C., McBey, B.A., Manuel, J., Croy, B.A., Marshall, J.S., et al 1997,Stress triggered abortions are associated with alterations of granulated cells into the decidua. Am. J. Reprod. Immunol. 37: 94–100.PubMedCrossRefGoogle Scholar
  23. Masuyama,. J., Yoshio, T., Suzuki, K., Kitagawa, S., Iwamoto, M., Kamimura, T., et al, 1999,Characterization of the 4C8 antigen involved in transendothelial migration of CD26(hi)T cells after tight adhesion to human umbilical vein endothelial cell monolayers. J. Exp.Med. 189: 979–990.PubMedCrossRefGoogle Scholar
  24. Morimoto, C., and Schlossman, S.F. 1998, The structure and function of CD26 in the T-cell immune response. Immunol. Rev. 161: 55–70.PubMedCrossRefGoogle Scholar
  25. Mrazkova, O., Grim, M., and Carlson, B.M., 1986, Enzymatic heterogeneity of the capillary bed of rat skeletal muscles. Am. J. Anat. 177: 141–148.PubMedCrossRefGoogle Scholar
  26. Nausch, I., Mentlein, R., and Heymann, E., 1990, The degradation of bioactive peptides and proteins by dipeptidyl peptidase IV from human placenta. Biol Chem. Hoppe Seyler 371:1113–1118.PubMedCrossRefGoogle Scholar
  27. Pauly, R.P., Demuth, H.U., Rosche, F., Schmidt, J., White, H.A., Lynn, F., Mcintosh, C.H.S.,and Pederson, R.A., 1999, Improved glucose tolerance in rats treated with the dipeptidyl peptidase IV (DP IV; CD 26) inhibitor Ile-thiazolidide. Metabolism 48: 385–389.PubMedCrossRefGoogle Scholar
  28. Pauly, R.P., Rosche, F., Wermann, M., Mclntosh, C.H., Pederson, R.A., and Demuth, H.U.,1996, Investigation of GIP1.42 and GLP-17.36 Degradation in vitro by Dipeptidyl Peptidase IV (DP IV) using Matrix-Assisted Laser Desorption/Ionization - Time of Flight Mass Spectrometry (MALDI-TOF MS): a Novel Kinetic Approach. J. Biol Chem. 271: 23222–23229.PubMedCrossRefGoogle Scholar
  29. Pederson,R.A., White, H.A., Schlenzig, D., Pauly, R.P., Mcintosh, C.H.S., and Demuth, till, 1998, Improved glucose tolerance in zucker fatty rats treated by oral administration of the dipeptidyl peptidase IV inhibitor isoleucyl thiazolidide. Diabetes 47: 1253–1258.PubMedCrossRefGoogle Scholar
  30. Plana, M., Vinas, O., De la Calle Martin, O., Lozano, F., Ingles Esteve, J., Romero, M., et al, 1991, Induction of interleukin 2 (IL 2) and interferon-gamma and enhancement of IL 2 receptor expression by a CD26 monoclonal antibody. Eur. J. Immunol. 21: 1085–1088.PubMedCrossRefGoogle Scholar
  31. Reinhold, D., Bank, U., Bühling, F., Lendeckel, U., Faust, J., Neubert, K., and Ansorge, S.,1997, Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factorbeta 1 in PWM-stimulated PBMC and T cells. Immunology 91:354.PubMedCrossRefGoogle Scholar
  32. Schmitz, T., Underwood, R., Khiroya, R., Bachovchin, W.W., and Huber, B,T., 1996 Potentiation of the immune response in HTV-1+ individuals. J. Clin. Invest 97: 1545–1549.PubMedCrossRefGoogle Scholar
  33. Stefanovic, V., Ardaillou, N., Vlahovic, P., Placier, S., Ronco, P., and Ardaillou, R., 1993,Interferon-gamma induces dipeptidylpeptidase IV expression in human glomerular epithelial cells. Immunology 80: 465–470.PubMedGoogle Scholar
  34. Suzuki, Y., Erickson, R.H., Sedlmayer, A., Chang, S.K., Ikehara, Y., and Kim, Y.S., 1993,Dietary regulation of rat intestinal angiotensin-converting enzyme and dipeptidyl peptidase IV. Am. J. Physiol. 264: Gl 153–G1159.Google Scholar
  35. Tanaka, T., Kameoka, J., Yaron, A., Schlossman, S.F., and Morimoto, C., 1993, The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity. Proc. Natl Acad. Sci. USA 90: 4586–90.PubMedCrossRefGoogle Scholar
  36. von Bonin, A., Steeg, C., Mittrucker, H.W., and Fleischer, B., 1997, The T-cell receptor associated zeta-chain is required but not sufficient for CD26 (dipeptidylpeptidase IV) mediated signaling. Immunol Lett. 55: 179–182.CrossRefGoogle Scholar
  37. Willheim, M., Ebner, C., Baier, K., Kern, W., Schrattbauer, K., Thien, R., et al, 1997, Cell surface characterization of T lymphocytes and allergen-specific T cell clones: correlation of CD26 expression with T(H1) subsets. J. Allergy Clin. Immunol. 100: 348–355.PubMedCrossRefGoogle Scholar
  38. Xu, X., and Chong, A.S., 1995, Cross-linking of CD45 on NK cells stimulates p561ckmediated tyrosine phosphorylation and IFN-gamma production. J. Immunol. 155: 5241–5248.PubMedGoogle Scholar
  39. Yaron, A., and Naider, F., 1993, Proline-dependent structural and biological properties of peptides and proteins. Crit. Rev. Biochem. Mol. Biol. 28: 31–81.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Martin Hildebrandt
    • 1
  • Hans-Ulrich Demuth
    • 2
  • Werner Reutter
    • 3
  1. 1.Department of Internal Medicine-PsychosomaticsMedizinische Fakultät Charité der Humboldt-Universität zu BerlinGermany
  2. 2.probiodrug Gesellschaft für Arzneimittelforschung mbHHalle/ SGermany
  3. 3.Institut für Molekularbiologie und BiochemieFachbereich Humanmedizin der Freien Universität BerlinGermany

Personalised recommendations